Article Details

OncoSec Medical (NASDAQ:ONCS) Upgraded to Buy at Zacks Investment Research

Retrieved on: 2021-01-09 08:51:51

Tags for this article:

Click the tags to see associated articles and topics

OncoSec Medical (NASDAQ:ONCS) Upgraded to Buy at Zacks Investment Research. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.21). As a group, research analysts ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo